Skip to main content

Characterization of Immune Responses to Pathogen Challenge by Ms-Based Epitope Mapping

  • Conference paper
Applications of Mass Spectrometry in Life Safety

Abstract

Mass spectrometry has long proven to be an outstanding bioanalytical technique for identifying proteins, defining their amino acid sequences, and for identifying sites of protein modifications. The application of mass spectrometry to more complicated biological structures, however, is less well established. We have been applying mass spectrometry to structural studies protein, especially to the determination of epitopes on proteins from pathogens that are recognized by monoclonal antibodies as part of the body’s immune system. As part of the defense mechanism against the invading pathogens, the body produces a cadre of antibodies to various epitopes on the pathogens. Here, we outline the development of epitope mapping techniques by mass spectrometry for the identification of linear epitopes and complex discontinuous epitopes using examples from our studies of epitopes on HIV proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hager-Braun, C., and Tomer, K. B. (2005) Determination of protein-derived epitopes by mass spectrometry. Expert Review of Proteomics 2, 745-756.

    Article  CAS  PubMed  Google Scholar 

  2. Jemmerson, R., and Paterson, Y. (1986) Mapping Epitopes on a Protein Antigen by the Proteolysis of Antigen-Antibody Complexes. Science 232, 1001-1004.

    Article  CAS  PubMed  Google Scholar 

  3. Suckau, D., Koehl, J., Karwath, G., Schneider, K., Casaretto, M., Bitter-Suermann, D., and Przybylski, M. (1990) Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping. Proc. Natl. Acad. Sci. U. S. A. 87, 9848-52.

    Article  CAS  PubMed  Google Scholar 

  4. Papac, D. I., Hoyes, J., and Tomer, K. B. (1994) Epitope mapping of the gastrin-releasing peptide/anti-bombesin monoclonal antibody complex by proteolysis followed by matrix-assisted laser desorption ionization mass spectrometry. Protein Sci 3, 1485-92.

    Article  CAS  PubMed  Google Scholar 

  5. Parker, C. E., Deterding, L. J., Hager-Braun, C., Binley, J. M., Schulke, N., Katinger, H., Moore, J. P., and Tomer, K. B. (2001) Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5. J. Virol. 75, 10906-10911.

    Article  CAS  PubMed  Google Scholar 

  6. Jeyarajah, S., Parker, C. E., Sumner, M. T., and Tomer, K. B. (1998) Matrix-assisted laser desorption ionization/mass spectrometry mapping of human immunodeficiency virus-gp120 epitopes recognized by a limited polyclonal antibody. J. Am. Soc. Mass Spectrom. 9, 157-165.

    Article  CAS  PubMed  Google Scholar 

  7. Hager-Braun, C., Katinger, H., and Tomer, K. B. (2006) The HIV-neutralizing monoclonal antibody 4E10 recognizes N-terminal sequences on the native antigen. J. Immunol. 176, 7471-7481.

    CAS  PubMed  Google Scholar 

  8. Coeffier, E., Clement, J. M., Cussac, V., Khodaei-Boorane, N., Jehanno, M., Rojas, M., Dridi, A., Latour, M., El Habib, R., Barre-Sinoussi, F., Hofnung, M., and Leclerc, C. (2000) Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein. Vaccine 19, 684-693.

    Article  CAS  PubMed  Google Scholar 

  9. Liang, X. P., Munshi, S., Shendure, J., Mark, G., Davies, M. E., Freed, D. C., Montefiori, D. C., and Shiver, J. W. (1999) Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein. Vaccine 17, 2862-2872.

    Article  PubMed  Google Scholar 

  10. Eckhart, L., Raffelsberger, W., Ferko, B., Klima, A., Purtscher, M., Katinger, H., and Ruker, F. (1996) Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus. J. Gen. Virol. 77, 2001-2008.

    Article  CAS  PubMed  Google Scholar 

  11. Muster, T., Guinea, R., Trkola, A., Purtscher, M., Klima, A., Steindl, F., Palese, P., and Katinger, H. (1994) Cross-Neutralizing Activity against Divergent Human-Immunodeficiency-Virus Type-1 Isolates Induced by the Gp41 Sequence Eldkwas. J. Virol. 68, 4031-4034.

    CAS  PubMed  Google Scholar 

  12. Binley, J. M., Sanders, R. W., Clas, B., Schuelke, N., Master, A., Guo, Y., Kajumo, F., Anselma, D. J., Maddon, P. J., Olson, W. C., and Moore, J. P. (2000) A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J. Virol. 74, 627-643.

    Article  CAS  PubMed  Google Scholar 

  13. Sanchez-Martinez, S., Lorizate, M., Katinger, H., Kunert, R., and Nieva, J. L. (2006) Mem- brane association and epitope recognition by HIV-1 neutralizing anti-gp41 2F5 and 4E10 antibodies. AIDS Res. Hum. Retroviruses 22, 998-1006.

    Article  CAS  Google Scholar 

  14. Ho, J., Uger, R. A., Zwick, M. B., Luscher, M. A., Barber, B. H., and MacDonald, K. S. (2005) Conformational constraints imposed on a pan-neutralizing HIV-1 antibody epitope result in increased antigenicity but not neutralizing response. Vaccine 23, 1559-1573.

    Article  CAS  PubMed  Google Scholar 

  15. Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., and Kwong, P. D. (2004) Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J. Virol. 78, 10724-10737.

    Article  CAS  PubMed  Google Scholar 

  16. McGaughey, G. B., Barbato, G., Bianchi, E., Freidinger, R. M., Garsky, V. M., Hurni, W. M., Joyce, J. G., Liang, X. P., Miller, M. D., Pessi, A., Shiver, J. W., and Bogusky, M. J. (2004) Progress towards the development of a HIV-1 gp41-directed vaccine. Curr. HIV Res. 2, 193-204.

    Article  CAS  PubMed  Google Scholar 

  17. Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F., and Katinger, H. (2001) A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 17, 1757-1765.

    Article  CAS  PubMed  Google Scholar 

  18. Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., and Parren, P. (2001) Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75, 10892-10905.

    Article  CAS  PubMed  Google Scholar 

  19. Cardoso, R. M. F., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., and Wilson, I. A. (2005) Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 22, 163-173.

    Article  CAS  PubMed  Google Scholar 

  20. Binley, J. A., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., Petropoulos, C. J., and Burton, D. R. (2004) Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78, 13232-13252.

    Article  CAS  PubMed  Google Scholar 

  21. Hochleitner, E. O., Borchers, C., Parker, C., Bienstock, R. J., and Tomer, K. B. (2000) Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis. Protein Sci. 9, 487-496.

    CAS  PubMed  Google Scholar 

  22. Williams, J. G., Tomer, K. B., Hioe, C. E., Zolla-Pazner, S., and Norris, P. J. (2006) The antigenic determinants on HIV p24 for CD4(+) T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometry. J. Am. Soc. Mass Spectrom. 17, 1560-1569.

    Article  CAS  PubMed  Google Scholar 

  23. Hager-Braun, C., and Tomer, K. B. (2002) Characterization of the tertiary structure of soluble CD4 bound to glycosylated full-length HIVgp120 by chemical modification of arginine residues and mass spectrometric analysis. Biochemistry 41, 1759-1766.

    Article  CAS  PubMed  Google Scholar 

  24. Iacob, R. E., Perdivara, I., Przybylski, M., and Tomer, K. B. (2008) Mass spectrometric characterization of glycosylation of Hepatitis C virus E2 envelope glycoprotein reveals extended micro-heterogeneity of N-glycans. J. Am. Soc. Mass Spectrom. 19, 428-444.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science + Business Media B.V

About this paper

Cite this paper

Williams, J.G., Deterding, L.J., Tomer, K.B. (2008). Characterization of Immune Responses to Pathogen Challenge by Ms-Based Epitope Mapping. In: Popescu, C., Zamfir, A.D., Dinca, N. (eds) Applications of Mass Spectrometry in Life Safety. NATO Science for Peace and Security Series A: Chemistry and Biology. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8811-7_9

Download citation

Publish with us

Policies and ethics